Articles tagged with "Drug Discovery"

Sort by

Pistoia Alliance announces first female president

June 24, 2022
Pistoia Alliance, the global body which promotes non-competitive R&D collaboration among leading life sciences organisations, has elected its first female president.

The voice of the empowered patient is on the rise

April 22, 2022
Industry experts agree that patient-centricity should be the overriding aim of global life science R&D and healthcare ecosystems in the wake of pandemic and huge technology-driven transformation. The Pistoia Alliance...

New antibiotic assessment mechanism to procure drugs to combat antimicrobial resistance (AMR)

April 20, 2022
One of the UK’s leading infectious disease biotech companies has lauded the conclusions of a project by NHS England and the National Institute for Health and Care Excellence (NICE). The...

Personalised medicine demands diversity in clinical trials

February 23, 2022
Equity requires us to recognise and celebrate our differences, especially when it comes to health. To exemplify the need for diversity in clinical trials, Daniel Cook discusses what the underlying...

Incorporating valuable microbiome data into drug development pipeline

February 16, 2022
A three-phase project will build a ‘Microbiome Atlas’ to power an algorithm for predicting the microbiome’s effect on the mechanisms of drugs in the body. This atlas will map out...

Making an impact in remote laboratory research

February 16, 2022
During Lab Innovations last November, Anna Cooper and Raymond Wong were delighted to pick up the ‘Most impactful laboratory research model or simulation award’ at the 2021 Lab Awards on...

BIA response to conclusion of NICE methods and processes review

January 31, 2022
BioIndustry Association expert expresses disappointment in the scope of the conclusions draw by NICE in its review of Health Technology Assessments methods and processes. By sticking so closely to what...

Pin It on Pinterest